AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
PharmaGap Inc announced that the National Cancer Institute (NCI) has confirmed receipt of PharmaGap's drug product PhG-alpha-1 at its drug depository in Rockville, MD, in advance of testing in the NCI's tumour cell panel consisting of 60 human cancer cell lines. The NCI has advised the company that the …